Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide

American Heart Journal

Volumn 143, Issue 3, 2002, Pages 406-411

  McNairy, Matthew ^a   Gardetto, Nancy ^b   Clopton, Paul ^b   Garcia, Alex ^b   Krishnaswamy, Padma ^b   Kazanegra, Radmila ^b   Ziegler, Michael ^a   Maisel, Alan S ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BRAIN NATRIURETIC PEPTIDE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; AGED; AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYCLING; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXERCISE; FEMALE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; OUTPATIENT CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VALIDATION PROCESS;

EID: 0036188430     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120148     Document Type: Article

References (39)

1. Prospects for using a blood sample in the diagnosis of heart failure
2. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
3. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A sub study of the studies of left ventricular dysfunction (SOLVD)
4. Hormones regulating cardiovascular function in patients with server congestive heart failure and their relation to mortality
5. Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
6. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials
7. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure
8. Biochemistry of natriuretic peptides
9. Adrenomedullin, endothelin, neuropeptide y, atrial, brain, and c-natriuretic prohormone peptides compared as early heart failure indicators
10. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
11. Brain natriuretic peptide predicts mortality in the elderly
12. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
13. A more sensitive and specific radioenzymatic assay for catecholamines
14. Mechanisms and models of heart failure: A combinatorial approach
15. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions and congestive heart failure
16. Natriuretic peptides-relevance in cardiac disease
17. Plasma brain natriuretic peptide in assessment of acute dyspnea
18. Utility of B-Type natriuretic peptide (BNP) in the diagnosis of chf in an urgent care setting
19. Neurohumoral measurements as indicators of long term prognosis after acute myocardial infarction
20. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
21. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
22. Utility of B-Natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic] in patients with and without symptoms of congestive heart failure at a Veterans hospital
23. Clinical criteria and biochemical markers For the detection of systolic dysfunction
24. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure
25. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
26. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise
27. Neuropeptide secretion in exercise
28. Effects of exercise on natriuretic peptides and cardiac function in man
29. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects
30. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction
31. Enhanced brain natriuretic peptide response to peak exercise in heart transplant recipients
32. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
33. Biosynthesis, secretion and receptor selectivity of human brain natriuretic peptide
34. Plasma atrial peptide concentration during acute changes in cardiac filling pressure induced by a contrast agent
35. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac hormone against ventricular overload
36. Secretion patterns of A-Type and B-Type natriuretic peptides in patients with hypertrophic cardiomyopathy or dilated cardiomyopathy
37. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations